STAT Plus exclusive IBM and its biggest partner in China are now scrambling to respond to the same doubts that emerged about Watson Health in the U.S. and Europe. httpsbuff.ly2PNRimwÂpic.twitter.comX0QMga31Rt

STAT Plus exclusive: IBM and its biggest partner in #China are now scrambling to respond to the same doubts that emerged about Watson Health in the U.S. and Europe. https://buff.ly/2PNRimw pic.twitter.com/X0QMga31Rt

20:00 EST 19 Dec 2018 | STAT

STAT Plus exclusive: IBM and its biggest partner in #China are now scrambling to respond to the same doubts that emerged about Watson Health in the U.S. and Europe. https://buff.ly/2PNRimw  pic.twitter.com/X0QMga31Rt

More From BioPortfolio on "STAT Plus exclusive: IBM and its biggest partner in #China are now scrambling to respond to the same doubts that emerged about Watson Health in the U.S. and Europe. https://buff.ly/2PNRimw pic.twitter.com/X0QMga31Rt"